FITC anti-mouse CD86 Antibody

Pricing & Availability
Clone
GL-1 (See other available formats)
Regulatory Status
RUO
Other Names
B7-2, B70, Ly-58
Isotype
Rat IgG2a, κ
GL-1_FITC_090707
LPS-stimulated (3 days) C57BL/6 mouse splenocytes stained with GL-1 FITC
  • GL-1_FITC_090707
    LPS-stimulated (3 days) C57BL/6 mouse splenocytes stained with GL-1 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability
105005 50 µg $94.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
105006 500 µg $280.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD86 is an 80 kD immunoglobulin superfamily member also known as B7-2, B70, and Ly-58. CD86 is expressed on activated B and T cells, macrophages, dendritic cells, and astrocytes. CD86, along with CD80, is a ligand of CD28 and CD152 (CTLA-4). CD86 is expressed earlier in the immune response than CD80. CD86 has also been shown to be involved in immunoglobulin class-switching and triggering of NK cell-mediated cytotoxicity. CD86 binds to CD28 to transduce co-stimulatory signals for T cell activation, proliferation, and cytokine production. CD86 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
LPS-activated CBA/Ca mouse splenic B cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The GL-1 antibody can block the mixed lymphocyte reaction in vitro and has been shown to inhibit the priming of cytotoxic T lymphocytes in vivo (along with antibodies against B7-1). Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemical staining of acetone-fixed frozen sections2,6, immunofluorescence microscopy, and in vivo and in vitro blocking of T cell responses1-6. GL-1 is not suitable for immunohistochemical staining of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 105051-105056).

Application References

(PubMed link indicates BioLegend citation)
  1. Hathcock KS, et al. 1993. Science 262:905. (Block, IP)
  2. Inaba KM, et al. 1994. J. Exp. Med. 180:1849. (Block, IHC)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Krummel MF, et al. 1995. J. Exp. Med. 182:459. (Block)
  5. Liu Y, et al. 1997. J. Exp. Med. 185:251. (Block)
  6. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  9. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  10. Klinger MB, et al. 2007. Am. J. Physiol. Requl. Integr. Comp. Physiol. 293:R677. PubMed
  11. de Verteuil DA, et al. 2014. J Immunol. 193:1121. PubMed
Product Citations
  1. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  2. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  3. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  4. Han J, et al. 2023. Front Microbiol. 13:1067725. PubMed
  5. Grenov A, et al. 2022. Cell Rep. 39:110778. PubMed
  6. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  7. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  8. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  9. Lu Y, et al. 2023. J Transl Med. 21:339. PubMed
  10. Kim EH, et al. 2020. Elife. 9:00. PubMed
  11. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  12. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  13. Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed
  14. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  15. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  16. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  17. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  18. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  19. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  20. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  21. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  22. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  23. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  24. Yan H, et al. 2022. J Nanobiotechnology. 20:280. PubMed
  25. Cho H, et al. 2022. Nat Commun. 13:5974. PubMed
  26. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  27. Blank A, et al. 2021. J Pathol. 253:160. PubMed
  28. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  29. Ma J, et al. 2021. Curr Protoc. 1:e144. PubMed
  30. Chen X, et al. 2022. J Appl Oral Sci. 30:e20220316. PubMed
  31. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  32. Liang Y, et al. 2014. J Immunol. 192:1277. PubMed
  33. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  34. Tsang J, et al. 2011. Int Immunopharmacol. 11:604. PubMed
  35. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  36. Pradhan K, et al. 2021. Front Immunol. 12:778830. PubMed
  37. Kurniawan H, et al. 2020. Cell Metabolism. 31(5):920-936. PubMed
  38. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  39. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  40. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  41. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  42. Vogel A, et al. 2022. STAR Protoc. 3:101653. PubMed
  43. Matundan H, et al. 2019. J Virol. 93. PubMed
  44. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  45. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  46. Liu J, et al. 2021. Front Immunol. 12:733808. PubMed
  47. Feng S, et al. 2021. Exp Ther Med. 21:20. PubMed
  48. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  49. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  50. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  51. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  52. Moon Y, et al. 2022. Theranostics. 12:1999. PubMed
  53. Lin R, et al. 2022. Cell Death Dis. 13:345. PubMed
  54. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  55. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  56. Smith LK, et al. 2021. Elife. 10:. PubMed
  57. Xue YL, et al. 2020. J Cell Mol Med. 24:12341. PubMed
  58. Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed
  59. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  60. Xu GY, et al. 2022. Small. 18:e2107838. PubMed
  61. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  62. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  63. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  64. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  65. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
  66. Aglas L, et al. 2018. J Allergy Clin Immunol. 142:984. PubMed
  67. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
RRID
AB_313148 (BioLegend Cat. No. 105005)
AB_313148 (BioLegend Cat. No. 105006)

Antigen Details

Structure
Ig superfamily, 80 kD
Distribution

B cells and T cells (upregulated upon activation), macrophages, dendritic cells, and astrocytes

Function
T cell costimulation, Ig class-switching, NK cell cytotoxicity
Ligand/Receptor
CD28, CD152 (CTLA-4)
Cell Type
Astrocytes, B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Hathcock KS, et al. 1993. Science 262:905.
3. Freeman GJ, et al. 1993. Science 262:907.
4. Carreno BM, et al. 2002. Annu. Rev. Immunol. 20:29.

Gene ID
12524 View all products for this Gene ID
UniProt
View information about CD86 on UniProt.org
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account